Cure Today20 小时
Blenrep Combo Accepted for FDA Review in R/R Multiple Myeloma
The FDA has accepted a biologics license application for Blenrep plus bortezomib or pomalidomide for patients with relapsed ...
Targeted Oncology1 天
November 2024 FDA Updates: Key Developments in Oncology
The FDA granted approval to nilotinib (Danziten) on November 14, 2024, for the treatment of adult patients with newly ...
Daily5 天
GSK fully liquid Menveo meningococcal vaccine approved by European Commission
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...